Vipadenant
|
|
|
- CAS-Nr.
- 442908-10-3
- Englisch Name:
- Vipadenant
- Synonyma:
- V 2006;CS-2294;BIIB 014;CEB 4520;VER 11135;Vipadenant;VER-ADO 49;VER-A 00-11;VER-A 00049;BIIB-014, CEB-4520
- CBNumber:
- CB52627600
- Summenformel:
- C16H15N7O
- Molgewicht:
- 321.34
- MOL-Datei:
- 442908-10-3.mol
|
Vipadenant Eigenschaften
- Schmelzpunkt:
- 245.3-246.1 °C
- Siedepunkt:
- 668.5±65.0 °C(Predicted)
- Dichte
- 1.56±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- DMSO:37.0(Max Conc. mg/mL);115.14(Max Conc. mM)
- Aggregatzustand
- A crystalline solid
- pka
- 4.27±0.30(Predicted)
- Farbe
- Light yellow to yellow
- InChI
- InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)
- InChIKey
- HQSBCDPYXDGTCL-UHFFFAOYSA-N
- SMILES
- C1(N)=NC(C2=CC=CO2)=C2N=NN(CC3=CC=C(N)C(C)=C3)C2=N1
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Vipadenant Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Vipadenant is a potent, selective and orally available adenosine A2A receptor antagonist under development for for Parkinson''s disease. Vipadenant demonstrates strong oral activity in commonly used models of Parkinson''s disease. Vipadenant has shown excellent preclinical pharmacokinetics and has successfully completed phase I clinical studies.
Vipadenant Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Vipadenant Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 88)Lieferanten
- Vipadenant(BIIB 014)
- 3-[(4-Amino-3-methylphenyl)methyl]-7-(2-furanyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine
- CEB 4520
- V 2006
- VER 11135
- VER-A 00049
- VER-A 00-11
- VER-ADO 49
- BIIB 014
- Vipadenant
- 5-BROMO-4-(METHYLSULFANYL)-1H-PYRROLO[2,3-B]PYRIDINE
- 3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine, 3-[(4-amino-3-methylphenyl)methyl]-7-(2-furanyl)-
- BIIB-014 Vipadenant
- BIIB-014;BIIB 014;BIIB014
- CS-2294
- 3-[(4-amino-3-methylphenyl)methyl]-7-(furan-2-yl)triazolo[4,5-d]pyrimidin-5-amine
- 3-(4-AMINO-3-METHYLBENZYL)-7-(FURAN-2-YL)-3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDIN-5- AMINE
- CEB 4520,Vipadenant,BIIB 014,BIIB014,CEB4520,inhibit,Adenosine Receptor,Inhibitor,P1 receptor
- BIIB-014, CEB-4520
- Vipadenant, 10 mM in DMSO
- 442908-10-3
- C16H15N7O
- Inhibitors
- API
